Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:DG 16:0_20:2)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003645 AN005984 Targeting the c-MYC/ELOVL6 Pathway Alters Cell Membrane Mechanics and Enhances Chemotherapeutic Efficacy in Pancreatic Cancer Cultured cells Human Cancer Universidad Francisco de Vitoria - Hospital 12 de Octubre LC-MS
ST003637 AN005973 lomitapide effects on lipidomics Pancreas Human Cancer Pennsylvania State University LC-MS
ST003629 AN005962 Impact of human PSMC5 gene mutations on neuronal development: Lipid profiling of PSMC5 mutant T cells T-cells Human Brain disease Leibniz Institute for Plasma Science and Technology LC-MS
ST003364 AN005511 Deep lipidomic profiling reveals sex dimorphism of lipid metabolism in fibro-calcific aortic valve disease Aortic valve tissue Human Heart disease Technical University Dresden LC-MS
ST002334 AN003810 Phospholipase D3 impact on the endolysosomal lipidome Cultured cells Human Alzheimers disease VIB-KU Leuven LC-MS
ST001687 AN002754 Non-transformed cells respond to fat by inducing glucose metabolism Liver Mouse VIB-KU Leuven Center for Cancer Biology LC-MS
ST001267 AN002104 Mass spectrometry-based lipidomics of oral squamous cell carcinoma tissue reveals aberrant cholesterol and glycerophospholipid metabolism Tongue Human Cancer University of Helsinki MS(Dir. Inf.)
  logo